GlassScriptPhysician profile
Samuel Hanlon
NPI 1295428589
$1,215.39
in general payments reported to CMS, 2019-2025
9 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $181 · 2024: $845 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $422.17 | 2024 | Axsos, Aequalis Flex Revive, Blueprint Patient Specific Instrumentation |
| Zimmer Biomet Holdings, INC. | $187.41 | 2023-2025 | Tapestry, Comprehensive Shoulder System, Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $147.91 | 2024 | Attune |
| Heron Therapeutics, INC. | $117.18 | 2023 | Aponvie |
| Orthofix Medical, INC. | $109.13 | 2024 | Spinal-Stim, Cervical-Stim |
| Lightbody Medical Technologies INC | $83.23 | 2024 | |
| Boston Scientific Corporation | $62.87 | 2025 | General - Pain Management |
| Davol INC. | $49.09 | 2025 | Arista |
| Sanara Medtech INC. | $36.40 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Hanlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.